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Inter-rater Reliability of Medication Error Classification in a Voluntary Patient Safety Incident Reporting 
System HaiPro in Finland 
ABSTRACT  
Background Medication errors are common in healthcare. Medication error reporting systems can be 
established for learning from medication errors and risk prone processes, and their data can be analysed 
and used for improving medication processes in healthcare organisations. However, data reliability testing 
is crucial to avoid biases in data interpretation and misleading findings informing patient safety 
improvement. Objective To assess the inter-rater reliability of medication error classifications in a voluntary 
patient safety incident reporting system (HaiPro) widely used in Finland, and to explore reported 
medication errors and their contributing factors. 
Method The data consisted of medication errors (n=32 592), including near misses, reported by 36 Finnish 
healthcare organisations in 2007–2009. The reliability of the original classifications was tested by an 
independent researcher reclassifying a random sample of errors (1%, n=288) based on narratives. The inter-
rater reliability of agreement (κ) of the classifications was calculated to describe the degree of conformity 
between the researcher and the original data classifiers. Descriptive statistics were used to describe the 
medication errors. 
Results The inter-rater reliability between the researcher and the original data classifiers was acceptable (κ 
≥0.41) in 11 of 42 (26%) medication error classes. Thus, these errors could be pooled from different 
healthcare units for the exploration of medication errors at the level of all reporting organisations. 
Contributing factors were identified in 48% (n=137) of the medication error narratives in the random 
sample (n=288). The most commonly reported errors were dispensing errors (34%, n=10 906), 
administration errors 25% (n=7 972), and documentation errors 17% (n=5 641). 
Conclusions The data classified by different classifiers can be pooled for some of the medication error 
classes. Consistency of the classification and the quality of narratives need improvement, as well as 
reporting and classification of contributing factors to provide high quality information on medication errors.  
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INTRODUCTION  
Medication errors are one of the most common incidents leading to adverse events in healthcare, occurring 
with approximately 1-2% of inpatients worldwide.
1
 Medication errors are defined as any preventable event 
that may cause or lead to inappropriate medication use or patient harm while the medication is under the 
control of a healthcare professional, patient, or consumer.
2
 One of the recommended strategies for 
learning from medication errors and risk prone processes is the establishment of national and local (e.g. 
hospital or unit based) medication error reporting systems.
3
 These systems are typically databases where 
healthcare professionals are able to file reports on medication incidents occurring in their daily practice. 
This data can be further analysed and used for improving medication processes in healthcare organisations.  
Some countries have introduced medication error reporting systems into their healthcare systems, but 
many of them are still maturing.
4
 Currently in Finland, over 200 health- and social care organisations report 
medication errors, including near misses, in an electronic patient safety incident reporting system HaiPro.
5
 
The HaiPro reporting system, launched in 2007, provides a great amount of information on the data 
reported and how the organisations have learnt from their incidents and improved their processes of care. 
The HaiPro system is primarily targeted at internal use in healthcare units, e.g., a paediatric unit within a 
larger hospital organisation, and hospital pharmacies. The HaiPro system can be accessed online through 
the organisation’s intranet. The reporting process is voluntary and anonymous. It is based on a systems 
approach;
6
 both error reporting and data analysis are confidential and blame-free. The HaiPro system also 
targets to identifying the root causes and contributing factors to errors in the reporting organisation, 
representing a key feature of a systems approach to error prevention.
7
 Furthermore, HaiPro encourages 
the organisations to change their erroneous processes and to track the impact of the changes to patient 
and medication safety.
8
   
In addition to serving as a local patient safety promotion tool, HaiPro has the potential to provide 
information on patient safety incidents at the level of all reporting organisations and so giving information 
on national medication safety promotion activities. Medication errors reported to HaiPro are classified by 
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local data classifiers, e.g., nurses in their respective healthcare organisations. This raises an issue of 
conformity and inter-rater reliability of the classifications even though the classifiers are given an 
introduction for classifying the narrative data in the reports.
9,10
 The generally accepted method for 
assessment of inter-rater reliability is to have two independent reviewers classify the same incidents.
10,11
 
The level of agreement between reviewers can then be determined by inter-rater reliability measures 
indicating the consistency of the ratings.
12
  
The aim of this study was to assess the inter-rater reliability of the information reported to HaiPro on 
medication errors. Similar reliability evaluations have been conducted for other patient safety incident 
reporting systems.
13–15
 The studies have found that reliability of classification systems of incidents has been 
a problem and hindering the use of the error data for research.
14,15
 Hence, the studies implicate the need 
for conducting such evaluations to ensure the quality of the medication error data used for informing the 
safety improvement strategies of healthcare organisations.    
The previous studies have mainly investigated the inter-rater reliability of medication error classification in 
relation to event type, preventability, and outcome severities.
14–16
 To our knowledge, this is the first study, 
in which the inter-rater reliability assessment covers all the classified information reported on medication 
errors in a patient safety incident reporting system. Based on the findings, recommendations will be 
suggested for improving the medication error reporting and classification processes of HaiPro and for 
similar systems in other countries to produce more reliable and high quality information on risky 
medication processes.  
METHODS 
Data and ethical approval 
The data comprised of all the patient safety incidents (n=64 405) reported to the HaiPro Incident Reporting 
System by personnel in 36 Finnish healthcare organisations during the pilot phase of HaiPro in 2007-2009. 
The majority of the reporting organisations provided specialized secondary and tertiary healthcare services. 
The total number of reporting units within these organisations was 2 090 and the number of healthcare 
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professionals able to file reports was approximately 52 000.
17
 During the pilot phase of Haipro, no hospital 
pharmacies were included in the reporting process; the hospital pharmacies have joined the reporting 
system afterwards. 
The HaiPro reporting process utilises an electronic data collection form in which structured and narrative 
information on the incident are reported by a healthcare professional (Appendix 1).
8,18
 The hospital units 
are able to classify and monitor their own incidents; after the incident has been reported in the hospital 
unit, a local data classifier, usually a unit nurse, classifies the narrative information by using a separate 
structured electronic data classification form (Appendix 1). The structured data and the classified 
information from the narratives are then analysed by the data classifiers.
8
 
This study concentrated on 32 592 medication errors, including near misses, within the pool of all patient 
safety incidents (n=64 405). The original data were stored in the databases of the reporting organisations. 
With their permission the data on these databases were pooled to form a single Excel-database for 
analysis.  
The approval for using the data for research was sought from the reporting organisations by the HaiPro 
Steering Committee which then granted permission to use the medication error data for the present study. 
An ethical approval was obtained through the ethical review process of the Vaasa Hospital District, Finland.  
Assessment of inter-rater reliability 
The narrative parts of the medication error reports 
18
 had been classified by different data classifiers in 
their respective organisations. The inter-rater reliability of the classifications was evaluated to indicate 
which elements of the narrative information could be pooled to form a larger data set for analysing 
medication errors at the level of all reporting organisations. For this purpose, a random sample of 1% 
(n=302) of errors was drawn from the data on medication errors (n=32 592) by using the PASW 18.0 
software (Figure 1). Errors not related to medications (n=14) were removed from the random sample. The 
process of inter-rater reliability testing is presented in Figure 1.   
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The inter-rater reliability of the classifications was evaluated by one researcher (RJ) re-classifying the 
random sample of medication errors (n=288) (Figure 1). The process was two-staged; in the first stage the 
classification method used by the researcher (RJ) was standardised by using another independent 
researcher (ARH). For this purpose, a systematic random sample of every third error (n=96) was drawn 
from the random sample and was re-classified by two researchers (RJ and ARH) (Figure 1). Following this, 
the inter-rater reliability of agreement between the researchers was measured using the PASW 18.0. 
statistical software. The researchers and the original data classifiers used the same classification form 
comprising 96 variables with different values (e.g. variable “nature of the error” had values: 1=near miss, 
2=actual error); each of the values was a yes/no selection in the classification process. 
Before classifying the systematic random sample of medication errors, the researchers reviewed the 
classification instructions provided to the original data classifiers. A few clarifications were made to the 
original instructions to enable thorough classification of the random sample of medication errors.  The 
classification process was based on the researchers’ in-depth understanding about the systems approach to 
medication error prevention, as well as their many years’ research and practical experience  and conducted 
studies in the area of medication error reporting and medication safety.  
In the second stage of the re-classification process, the first researcher (RJ) independently classified the 
remaining medication error narratives (n=192) in the random sample (Figure 1). Following this, 
classifications made by the first researcher (RJ) were compared to the classifications of the original data 
classifiers to test the reliability of the whole data on medication errors. 
The inter-rater reliability was measured by using Cohen’s kappa (κ) to describe the degree of conformity 
between the two researchers (RJ and ARH), as well as between the study researcher (RJ) and the original 
data classifiers.
12
 Cohen’s kappa is the most commonly used statistic for categorical items to measure the 
agreement between two reviewers in studies of patient safety incidents.
10,12
 The degree of agreement by 
the reviewers is established by interpreting the kappa value. In the present study, the degree of agreement 
was considered acceptable when resulting in kappa values of 0.41 or above.
19
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
7 
 
The kappa values for some of the variables in the systematic random sample of 96 medication errors were 
low (see Table 1; κ I) when calculating inter-rater reliability between the study researchers (Figure 1). 
Consequently, the classification instructions were revised to better standardise the classification process. 
Following this, both researchers independently reviewed their own classifications by using the revised 
classification instructions (Figure 1).  
Description of the medication errors 
Descriptive statistics were used for describing the reported medication errors. The variables with a high 
enough agreement rate (κ≥0.41) were described at the level of the entire data (n=32 592) (Figure 1).
12,20
 
The variables with κ<0.41 were described at the level of the random sample (n=288) based on 
classifications made by the researcher (RJ). Cross-tabulation and frequencies were used to present the 
results. The analyses were performed through the use of Microsoft Excel and PASW 18.0. statistical 
software. 
 
RESULTS 
Inter-rater agreement of medication error classifications  
The agreement rate between the two researchers (RJ and ARH) was acceptable (κ≥0.41) for 40 out of 41 
variables for which the kappa value was possible to be calculated in the random sample of medication 
errors (n=288) (Table 1). Between the researcher (RJ) and the original data classifiers the acceptable rate of 
agreement was achieved for 11 out of 42 variables. Thus, these medication error variables were classified 
with such a degree of consistency by the classifiers in different reporting healthcare organisations that it is 
possible to analyse them descriptively in the whole data set (n=32 592) (Figures 2 and 3). These 11 variables 
were related to: the nature of the error; the type of the error; medication documentation errors; 
dispensing errors; administration errors, and storage errors. However, for storage errors confidence 
intervals resulted in poor values. 
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The degree of conformity between the study researcher (RJ) and the original classifiers did not reach the 
agreed acceptable level for the majority of the variables on medication errors (Table 1). The researchers 
were also able to identify more circumstances and contributing factors in the medication error narratives 
than the original data classifiers had classified (Figure 4). The data with acceptable level of agreement and 
the conditions and contributing factors to medication errors are presented in the following.   
Data with an acceptable level of agreement 
Almost half of the reported medication errors (n=32 592) were actual errors by their nature and the other 
half were near misses (Figure 2). While the error type (e.g., a dispensing error) was reported for 82% (n=26 
680) of all errors, it was unknown for 18% (n=5 912). The majority of the reported medication errors and 
near misses were dispensing errors at the units (33%, n=10 906), administration errors (24%, n=7 972) and 
medication documentation errors (17%, n=5 641). Figure 3 shows the most frequent types of medication 
errors identified. 
 
Conditions and contributing factors 
Conditions and contributing factors to medication errors resulted in low level of agreement and are 
therefore presented at the level of the random sample (n=288) based on the classifications by the 
researcher (RJ). The working conditions at the time of the error and other contributing factors were 
described for half (48%, n/N=137/288) of the reported medication errors. The most common contributing 
factors were: deficiencies in communication and flow of information between healthcare professionals or 
units involved in patient care (53%, n/N=72/137); deficiencies in working patterns (34%, n/N=46/137), and 
deficiencies in work environment, tools and resources (33%, n/N=45/137). However, contributing factors 
associated with the organisation and leadership were not reported for any errors. The frequencies of other 
contributing factors were: inadequate training, introduction and competence of healthcare personnel (12%, 
n/N=17/137); patient and his/her carer (12% n/N=16/137); medicines (9%, n/N=12/137); deficiencies in 
team work (4%, n/N=6/137), and devices or instruments (1%, n/N=2/137). Other data on consequences to 
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hospital unit and the patient and the situation management and immediate actions that remained low in 
inter-rater reliability are not presented in this paper. 
DISCUSSION  
HaiPro is a unique reporting system and a comprehensive tool for healthcare organisations to improve their 
patient safety and medication processes. The study shows that information on the nature and type of 
medication errors, and the sub-types of medication documentation, dispensing and administration errors 
could be pooled from different healthcare units for their exploration at the level of all healthcare 
organisations using HaiPro. The study indicates that the reporting and classification of error circumstances 
and contributing factors need to be improved to provide more detailed system-based information for 
medication safety promotion activities in the reporting healthcare organisations.  
Many variables, e.g., outcomes of medication errors to a patient and hospital organisation, had low in inter-
rater reliability between the researcher and the original data classifier. This indicates the need to improve 
the quality and conformity of medication error reports and their classification. In this task, obtaining 
comprehensive narratives on reported medication errors is key; many narratives in the current data did not 
have enough information to enable complete classification of the error or to identify contributing factors.  
Moreover, in 18% of the narratives the type of the medication error was not reported, or the data classifier 
was not able to identify the type of the error. Also, the circumstances and contributing factors could be 
classified for only a half of the reported errors in our sample as the narratives did not always provide the 
necessary information. These findings call for educational actions to ensure that all healthcare personnel 
understand why reporting of errors is necessary and what information needs to be reported to identify 
unsafe medication processes and to plan safety improvements.
21,22
 The findings may also reflect the 
inherent limitations of retrospective incident analysis where immediate factors (such as a defective infusion 
pump) are more easier to identify than the distal factors (such as poor leadership).
23
 Similar findings have 
been reported for other incident reporting systems with a large number of reporting fields left empty, 
resulting in loss of necessary information.
13,24
 Further research is needed to determine whether filing 
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incomplete reports is primarily a competence issue or the result of a lack of time or motivation for 
reporting.
4,25
 
According to this study, the data classifiers could benefit from additional guidance or training especially 
concerning the classification of medication error circumstances and contributing factors. Classification of 
these variables did not reach an acceptable level of conformity between the researcher and the original 
data classifiers. The researchers were also able to identify and classify more circumstances and contributing 
factors from the same narratives than the original data classifiers. This may reflect the researchers’ more 
comprehensive understanding about systems approach as a theoretical framework for error prevention 
and, therefore, enable them to explore the contributing factors in the medication error narratives in more 
detail. Furthermore, understanding the systems approach enables the identification of the possible 
contributing factors in the healthcare organisation as a system instead of solely focusing on individual 
personnel members, e.g., their lack of competence.
7
 Consequently, it must be ensured that the reporting 
personnel and the data classifiers have sufficient understanding of the systems approach, in order to 
provide the needed information for healthcare organisations to plan system based actions for medication 
error prevention. In addition to the competence issues of healthcare staff, the lack of cultural maternity of 
the reporting organisation may contribute to poor incident reports and their classification although the 
reporting system itself would espouse the systems approach.
25
 These findings may contribute to underuse 
of the HaiPro system and possibly similar systems in other countries in detecting circumstances and 
contributing factors to incidents. These aspects should be noted by the hospital management level when 
allocating the required resources for incident reporting.
25,26
  
The achieved conformity of classifications between the two study researchers indicates that it is possible to 
classify the medication errors in a unanimous way by developing and using a detailed standard method for 
classifications and by basing the classification on the systems theory.
6
 The additions made to the HaiPro 
data classification instructions in our study may also explain the higher conformity achieved between the 
researchers. Therefore, improving the unambiguity of the classification instructions and standardising the 
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classification process to the highest extent possible, may provide one solution for increasing the inter-rater 
reliability of classifications. Furthermore, the reporting form and procedure should be designed 
appropriately to enable functional reporting.
25,27
 From the pharmacy practice perspective, it should also be 
considered whether the pharmacists would be the best suited healthcare professionals for classifying the 
medication error data and participating the healthcare teams driving the safety improvements.  
Our findings support the need for improving the dispensing, administration and medication documentation 
stages of the medication process in hospitals.
26,28
 In approximately a quarter of the reported errors the 
medication was “not documented”, “not dispensed” or “not administered” to a patient. These all represent 
an error of omission, increasing the risk of the patient being left without the prescribed medication.
29
 
Consequently, our findings show the need to decrease this type of risk which has been identified as the 
most common medication process-related risk in healthcare organisations.
30
  
Strengths and Limitations  
The random sample of incidents included only a few less reported medication error types (e.g., errors in 
prescribing and preparing medications for administration), possibly due to under-reporting of these errors. 
This may have influenced on the validity of the reliability testing. Hence, it was not possible to calculate the 
kappa-value for these error types. Additional research employing inter-rater reliability testing is needed 
especially for data samples of less reported medication errors to draw final conclusions about the quality of 
medication error classifications in HaiPro.  
The data set was not drawn from all healthcare organisations in Finland; only a number of the organisations 
participated in the HaiPro pilot programme in 2007-2009 with the majority of them being special 
healthcare units. However, our study provides preliminary results of the reliability of the medication error 
classifications in the HaiPro and recommendations for designing and improving similar systems in other 
countries.  
The methods employed in this study proved to be rather time-consuming. Plenty of standardisation was 
required between the researchers to gain the required level of conformity when classifying the medication 
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errors. Thus, trained data classifiers familiar with the operational environments of the reporting hospital 
units are recommended to be used in future studies instead of researchers who may tend to be “neutral” 
or “academic” in relation to the actual everyday practice in healthcare where the errors occur and are 
classified.  
Recommendations 
The findings of this study provide central information for designing, implementing and managing 
medication incident reporting systems. First of all, learning from medication errors requires reliable 
reporting.
31
 Therefore, from the research perspective, it is recommended to conduct similar evaluations, as 
described in our study, on other patient and medication safety incident reporting systems as a part of 
quality assurance of the produced data. Data reliability testing is crucial, especially for systems collecting 
reports from different healthcare organisations, to avoid biases in data interpretation and misleading 
findings informing patient safety improvement actions. Data reliability testing and a standard system for 
incident classification might also benefit the local reporting in healthcare organisations, especially when 
multiple data classifiers exist. The findings of this study may also be regarded as equally valuable for 
incident reporting systems in community pharmacies. Indeed, it would be most effective to use the same 
reporting system and database in both hospital and community settings to maximize the learning 
opportunities from errors.   
For future research studies, some additional methods, such as consensus panels for those classifying the 
incidents,
16
 is recommended to be included to complete the reliability testing. Observational studies may 
also be needed to determine the actual occurrence of medication errors and near misses, and their 
contributing factors.
32
 
CONCLUSIONS 
The nature of a medication error; the type of the error; medication documentation errors; dispensing 
errors, and administration errors can be pooled from different healthcare units for exploration of 
medication errors at the level of all organisations using HaiPro in Finland. Comprehensive medication error 
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narratives providing sufficient and detailed information are key, and need to be targeted by educational 
efforts for the reporting personnel. It must be ensured that the data classifiers have sufficient 
understanding of the systems approach to error prevention and skills to classify the medication error 
narratives, especially in relation to circumstances and contributing factors which may lead to errors.  
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Table 1 Inter-rater reliability of medication error classifications in the random sample of medication errors 
(n=288) for which the kappa (κ) was able to be calculated*. κ (I) describes the agreement between 
two independent researchers and κ (II) stands for the agreement between the researcher and the 
original data classifiers. Acceptable agreement rates (κ≥0.41) are in bold. Each classification is a 
yes/no selection in the used classification system. 
Classification 
Agreement between two 
independent researchers 
Agreement between the 
researcher and the original 
data classifiers
 
κ (95% Cl)  
n=96 
κ (95% Cl) 
n=x* 
Nature and type of the medication error 
Nature of the error (near miss or 
actual error) 
0.81 (0.71 to 0.92) 
0.83 (0.76 to 0.90) 
n=242 
Type of the error known 0.49 (-0.12 to 1.10) 
0.21 (0.06 to 0.35) 
n=288 
Type of the error 0.81 (0.72 to 0.91) 
0.63 (0.56 to 0.69) 
n=284 
Type of dispensing error (at the unit) 
known 
0.86 (0.76 to 0.97) 
0.67 (0.58 to 0.75)  
n=288 
Type of the dispensing error 0.82 (0.70 to 0.93) 
0.67 (0.58 to 0.74) 
n=280 
Type of administration error known 0.85 (0.74 to 0.97) 
0.67 (0.56 to 0.77) 
(n=287) 
Type of the administration error 0.83 (0.72 to 0.94) 
0.57 (0.47 to 0.68) 
n=286 
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Type of medication documentation 
error known 
0.85 (0.74 to 0.97) 
0.65 (0.54 to 0.76) 
n=280 
Type of the medication 
documentation error 
0.85 (0.74 to 0.96) 
0.59 (0.49 to 0.69)  
n=288 
Type of storage error known 0.66 (0,04 to 1.28) 
0.57 (0.125 to 1.00) 
n=288 
Type of the storage error (e.g. wrong 
storage conditions) 
0.66 (0,04 to 1.28) 
0.66 (n=287) 
(0.22 to 1.10) 
Type of prescription error known 0.66 (0.22 to 1.10) 
0.65 (0.43 to 0.88) 
n=288 
Outcome for the patient 
Outcome for the patient known 0.66 (0.50 to 0.82) 
0.08 (-0.02 to 0.17) 
(n=288) 
Patient harmed 0.68 (0.56 to 0.81) 
0.21 (0.13 to 0.29) 
(n=288) 
Severity of the outcome to the 
patient 
0.36 (0.17 to 0.56) 
0.18 (0.08 to 0.29) 
(n=286) 
Outcome for the hospital unit 
Outcome for the unit known 0.59 (0.43 to 0.75) 
0.06 (-0.03 to 0.15)  
(n=288) 
The error caused harm to the unit 0.60 (0.46 to 0.73) 
0.10 (0.03 to 0.19) 
(n=288) 
Image harm to the unit 0.54 (0.37 to 0.70) 
0.07 (-0.01 to 0.14) 
(n=288) 
Material loss  0.52 (0.36 to 0.69) 0.07 (-0.02 to 0.15) 
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(n=288) 
Extra financial costs 0.53 (0.36 to 0.70) 
0.07 (-0.02 to 0.16)  
(n=288) 
Additional work or minor care for the 
patient 
0.56 (0.43 to 0.70) 
0.08 (0.00 to 0.15)  
(n=288) 
Prolonged care for the patient e
** 
0.08 (-0.01 to 0.17)  
(n=288) 
Long-term care for the patient  0.51 (0.34 to 0.68) 
0.07 (-0.02 to 0.16)  
(n=288) 
Personnel harmed 0.53 (0.36 to 0.70) 
0.07 (-0.02 to 0.16) 
(n=288) 
Other individuals harmed 0.53 (0.36 to 0.70) 
0.07 (-0.02 to 0.16)  
(n=288) 
Management of the error situation 
Management of the error known 0.83 (0.72 to 0.94) 
0.14 (0.05 to 0.24) 
(n=288) 
Error managed by those involved in 
the situation 
0.83 (0.72 to 0.94) 
0.13 (0.04 to 0.23) 
(n=288) 
Extra personnel called out 0.83 (0.72 to 0.94) 
0.13 (0.05 to 0.22) 
(n=288) 
Immediate actions 
Immediate actions known 0.79 (0.66 to 0.91) 
0.15 (0.05 to 0.25) 
(n=288) 
Actions taken to correct the error 0.76 (0.65 to 0.87) 
0.24 (0.16 to 0.47)  
(n=288) 
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Patient observed and/or informed  0.75 (0.63 to 0.87) 
0.22 (0.13 to 0.30) 
 (n=288) 
Actions taken to mitigate the effects 
of and additional harm caused by the 
error 
0.60 (0.46 to 0.74) 
0.16 (0.08 to 0.24) 
(n=288) 
Working conditions and other contributing factors 
Conditions and other contributing 
factors known 
0.79 (0.67 to 0.91) 
0.22 (0.11 to 0.43) 
(n=288) 
Communication and flow of 
information 
0.72 (0.60 to 0.84) 
0.21 (0.15 to 0.30) 
(n=288) 
Working patterns 0.68 (0.56 to 0.80) 
0.15 (0.06 to 0.24) 
(n=288) 
Work environment and tools, 
resources 
0.77 (0.66 to 0.88) 
0.22 (0.13 to 0.32) 
(n=288) 
Patient and his/her carer  0.74 (0.62 to 0.86) 
0.23 (0.13 to 0.33) 
(n=288) 
Education and orientation, 
competence of personnel 
0.76 (0.63 to 0.88) 
0.23 (0.13 to 0.33) 
(n=288) 
Medicines 0.75 (0.63 to 0.87) 
0.20 (0.09 to 0.30) 
(n=288) 
Team or group work 0.74 (0.61 to 0.87) 
0.19 (0.08 to 0.30) 
(n=288) 
Devices or instruments 0.80 (0.68 to 0.92) 
0.20 (0.09 to 0.31) 
(n=288) 
Organisation and leadership 0.79 (0.67 to 0.91) 0.21 (0.09 to 0.32) 
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(n=288) 
Footnotes: 
 
Interpretation of the kappa-values: 1.00 complete agreement; 0.81–1.00 almost perfect agreement; 0.61–
0.80 substantial agreement, 0.41–0.60 moderate agreement, 0.21–0.40 fair agreement; 0.00–0.20 slight 
agreement, and <0.00 poor agreement or less than agreement by chance. 
* Some classifications which prevented the calculation of the kappa were removed as only one of the 
reviewers had used some specific value related to the classification, resulting in a varying number (n) of 
classifications  
** 
Calculation not possible as only one of the reviewers has used the classification 
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Figure 1 The phases related to handling and analysis of the data from the HaiPro Incident Reporting 
System.  
Figure 2 The reported medication errors as percentages in the data set (n=32 592) from the different 
healthcare organisations using the HaiPro system. 
Figure 3 Defined types of the most frequent medication errors in the data (n=32 592) from different 
healthcare organisations using the HaiPro system. The level of inter-rater agreement was found acceptable 
(κ≥0.41) for the presented error types.  
Figure 4 An example of the contributing factors classified by the original data classifier and the researcher 
based on the narrative of a medication error reported by a personnel member in a hospital unit using the 
HaiPro system. 
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Errors related to medications, blood transfer and 
contrast or tracer agents 
n = 32 696 
Actual errors and near misses 
n = 32 605 
All patient safety incidents  
n = 64 405 
Cases of violence against healthcare 
personnel 
n = 91 
Random sample of 1% 
n = 302 
Final data 
n = 32 592 
Other than errors related to 
medications, blood transfusion and 
contrast or tracer agents 
n = 31 709 
Falsely classified incidents 
n = 13 
Errors related to blood transfer and 
contrast or tracer agents 
n = 14 
   Agreement between the researchers (I) 
• Re-classification of the random sample (n=96) of incidents by two researchers (RJ & ARH) 
• Assessing the inter-rater reliability of agreement on classifications by Cohen’s kappa 
   Agreement between the researchers (II) 
• A few clarifications made to the classification guidelines for the researchers (RJ & ARH) and 
reviewing the classifications 
• Re-assessing the inter-rater reliability of agreement on classifications by Cohen’s kappa 
   Agreement between the researcher and the original data classifier (III) 
• Classifying the rest of the sample (n=288) by the other researcher (RJ) 
• Assessing the inter-rater reliability of agreement on classifications by Cohen’s kappa 
• Conclusions about the reliability of the classifications and the validity of the data 
 
   Descriptive statistics 
• Describing the features (e.g., error type) of medication errors resulting in an acceptable agreement 
at the level of all data (n= 32 592) 
• Describing the contributing facotrs of medication errors resulting in low agreement at the level of 
the random sample of medication incidents (n=288) classified by the researcher (RJ) 
A
n
a
ly
si
s 
  
Excluded from the data 
Systematic random sample  
n=96 
Final random sample of medication errors  
n=288 
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Figure 1  
 
 
Figure 2  
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Defined types of medication documentation errors (n=5 641) as percentages 
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Figure 3.  
 
Figure 4  
  
Narrative 
An 88-year old male patient with a broken hip was waiting for surgery. The patient received Oxynorm 6 
mg s.c. at 08.55 prescribed by a doctor.  
The patient became sleepy after one hour from receiving the medication. He experienced respiration 
arrests and was therefore transferred to the observation unit (also head ct was ordered and nothing 
pathological was found). The situation was corrected in the observation unit within a few hours. Later in 
the evening the patient was operated under spinal anesthesia. An epidural anesthetic infusion and p.o. 
paracetamol was administered for pain.  
Consequently, the patient had a respiration arrest, causing a hazardous situation for the patient. The 
patient was transferred to observation and the operation was delayed. The instructional dose of 
Oxynorm s.c . for an elderly patient is 3 mg which is half of the administered dose.  
I am wondering does this situation recur daily or weekly without our notice? 
Contributing factors classified by the original  
data classifier 
• Education and orientation, 
competence 
• Knowledge and skills 
 
Contributing factors classified by the 
researcher 
• Education and orientation, 
competence 
• Knowledge and skills 
• Working patterns and methods 
• Availability and use of instructions, 
guidelines and other written 
information related to the task 
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Appendix 1 Information on the patient safety incidents collected by the HaiPro Incident Reporting System 
in the Pilot Phase of 2007-2009 (1). 
Information provided by the healthcare professional reporting the incident 
Reported through structured drop-down menus in the electronic HaiPro reporting form (2) 
       Date incident occurred 
       Unit of the healthcare professional reporting the incident 
       Unit were the incident occurred 
       Profession of the person reporting the incident 
       Date and time of the incident 
       Place of occurrence (e.g. operating room) 
       Nature of the incident (actual error, near miss or violation directed to personnel) 
       Incident type (e.g. dispensing error of a medicine) 
Reported as open narratives in the HaiPro reporting form (2) 
       Description of the incident 
• What happened and how the incident occurred 
• What were the consequences for the patient and the unit 
• Conditions at the time of the incident and other contributing factors 
• Views of the reporting person on how similar incidents could be avoided in the future 
       Suggestions for action to prevent re-occurrence of the incident 
Information classified by the data classifier (based on reported narratives) by a structured electronic 
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data classification form 
       Defined type of the incident (e.g. a wrong medicine dispensed to a patient) 
       Consequences for the patient and the unit 
       Management of the incident situation 
       Instant actions in the incident situation 
       Conditions at the time of the incident and other contributing factors (e.g. lack of information on the 
       medicines the patient is using) 
Information reported by the data classifier as an open narrative in the HaiPro system 
       Actions to prevent the re-occurrence of the incident suggested by the reporter, or 
       explanation of why actions are not needed 
       Description of how the suggested actions were executed 
1. Ministry of Social Affairs and Health. Introduction of a reporting system for dangerous situations in 
health care. [Abstract in English]. Reports of the Ministry of Social Affairs and Health 2008:16.  
2. Awanic Ltd. HaiPro – Patient safety incident report: http://83.150.87.4/haipro/20/lomake.asp?kieli=ENG. 
Accessed [215 Sep 2].  
 
 
 
